<DOC>
	<DOCNO>NCT01025063</DOCNO>
	<brief_summary>This study investigate safety efficacy treatment choroidal neovascularization ( CNV ) due age-related macular degeneration ( AMD ) combination ranibizumab ( Lucentis ) verteporfin PDT ( Visudyne ) , compare ranibizumab monotherapy .</brief_summary>
	<brief_title>Use Spectral OCT Combination Therapy</brief_title>
	<detailed_description />
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization , Pathologic</mesh_term>
	<mesh_term>Ranibizumab</mesh_term>
	<criteria>Ability give inform consent Patients visual acuity 20/4020/320 study eye Subfoveal choroidal neovascularization ( CNV ) must least 50 % total lesion size . Total area lesion component CNV must less 50 % total lesion size . The lesion must &lt; 5400microns great linear dimension ( GLD ) . Lesion size &lt; 10 DA Occult classic CNV lesion must presume recent disease progression : 1 . Blood associated lesion baseline 2 . Loss visual acuity previous 3 month : : &gt; 5 letter loss ( ETDRS equivalent ) b : 2 line use snellen equivalent chart 3 . &gt; 10 % increase GLD assess fluorescein angiography previous 3 month Presence angioid streak , presume ocular histoplasmosis syndrome , pathologic myopia ( 8 evidence posterior segment abnormality consistent pathologic myopia ) , CNV secondary cause AMD Geographic atrophy study eye Tear ( rip ) retinal pigment epithelium Presence fibrosis , hemorrhage , pigment epithelial detachment , hypofluorescent lesion obscure great 50 % CNV lesion Intraocular surgery within 6 week enrollment Active history ocular inflammation infection study eye within last 30 day Subretinal hemorrhage &gt; 50 % total lesion History submacular surgery , transpupillary thermotherapy study eye Patients intraocular pressure great 30 mm/Hg 2 pressurelowering medication Patients severe disciform scar History intraocular surgery study eye include par plana vitrectomy , except uncomplicated cataract surgery within 60 day prior screen History YAG laser posterior capsulotomy study eye within 30 day prior screen Inability make study visit Advanced glaucoma , uncontrolled glaucoma study eye ( defined intraocular pressure , IOP ≥ 25 mmHg ) despite treatment two topical pharmacological antiglaucomatous medication ) Allergies porphyrins know hypersensitivity component Visudyne® Patients porphyria Pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Spectral OCT</keyword>
	<keyword>Choroidal Neovascularization</keyword>
	<keyword>Lucentis</keyword>
	<keyword>Visudyne</keyword>
	<keyword>PDT</keyword>
	<keyword>anti-VEGF</keyword>
</DOC>